Eagle Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
VC/PE Firms | 1,211,509 | 9.33% |
General Public | 1,365,489 | 10.5% |
Individual Insiders | 1,445,251 | 11.1% |
Hedge Funds | 1,962,070 | 15.1% |
Institutions | 7,002,652 | 53.9% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
1,962,070 | US$1.8m | 55.9% | 0.38% | |||
1,364,944 | US$1.2m | 0% | no data | |||
1,211,509 | US$1.1m | 2.11% | 1.17% | |||
1,001,555 | US$901.3k | 36,700% | no data | |||
694,782 | US$625.2k | -20.8% | no data | |||
564,396 | US$507.9k | -11.9% | no data | |||
352,762 | US$317.5k | -60.7% | no data | |||
325,519 | US$292.9k | 0.1% | no data | |||
295,388 | US$265.8k | -11.6% | no data | |||
247,718 | US$222.9k | -11.6% | no data | |||
244,250 | US$219.8k | -26.8% | no data | |||
224,817 | US$202.3k | -4.87% | no data | |||
195,475 | US$175.9k | -24.1% | no data | |||
191,111 | US$172.0k | -26.1% | 0.01% | |||
185,337 | US$166.8k | 0% | no data | |||
176,361 | US$158.7k | 0% | no data | |||
173,365 | US$156.0k | 0% | 0.01% | |||
171,008 | US$153.9k | -22.2% | no data | |||
167,782 | US$151.0k | -34.9% | no data | |||
133,944 | US$120.5k | -18% | no data | |||
132,606 | US$119.3k | -30.8% | no data | |||
128,087 | US$115.3k | 0% | 0.01% | |||
118,857 | US$107.0k | 0% | 0.02% | |||
108,004 | US$97.2k | -53.4% | no data | |||
94,062 | US$84.6k | -5.47% | no data |